Sepsis, a life-threatening organ dysfunction, is responsible for an estimated 1 in 5 deaths globally and 1 in 3 deaths that ...

Recent federal developments may soon require cosmetic companies to adopt stringent precautions to ensure that talc-containing ...

The National Drug Law Enforcement Agency, NDLEA, says some state governments in the country have embraced its advocacy to ...

The FDA has updated the product labeling for Xeloda and 5-FU to highlight the risks associated with dihydropyrimidine ...

You probably think “antibiotic resistance” means that a bacterial infection can’t be cured by any antibiotics. But the FDA ...

NDLEA says it has recorded some achievements in its war against the abuse of narcotic substances especially with sub-nationals.

Company highlights key milestones achieved in 2024, growing revenues and progress towards U.S. expansion in 2025. NEW YORK, Feb. 10, 2025 (GLOBE NEWSWIRE) -- Intelligent Bio Solut ...

Surgeons at Massachusetts General Hospital have successfully performed the fourth pig kidney transplant in the U.S.&nb ...

The telehealth company Hims & Hers put out a Super Bowl ad that skimped on clarifying that its compounded semaglutide ...

Rider's Choice, a program that allowed Uber and Lyft to provide some NJ Transit Access Link riders, will be transitioning to ...

I Asked 5 Food Experts To Name the Best Dumplings Brand—And They All Said the Same Thing The Philadelphia Eagles won the ...

Emblaveo will be available in the third quarter of 2025 to treat patients with intra-abdominal infections, a common cause of sepsis in the intensive care unit.